The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 22, 2017
Filed:
Mar. 21, 2014
Aikaterini Kontrogianni-konstantopoulos, Ellicott City, MD (US);
Konstantinos Konstantopoulos, Ellicott City, MD (US);
Marey Shriver, Nottingham, MD (US);
Nicole Perry, Baltimore, MD (US);
Aikaterini Kontrogianni-Konstantopoulos, Ellicott City, MD (US);
Konstantinos Konstantopoulos, Ellicott City, MD (US);
Marey Shriver, Nottingham, MD (US);
Nicole Perry, Baltimore, MD (US);
UNIVERSITY OF MARYLAND, BA, Baltimore, MD (US);
JOHNS HOPKINS UNIVERSITY, Baltimore, MD (US);
Abstract
Provided herein are methods and kits for evaluating potential for invasiveness, metastasis, or recurrence of an epithelial cell cancer. In the methods the expression profile of giant obscurins is detected in a tissue sample of tumor cells or suspected tumor cells and assessed for giant obscuring expression level and distribution therein. Decreased levels or altered distribution of giant obscurins in the cells compared to a control non-invasive standard or to a sample taken at a different point in time is indicative of increased potential of at least one of the invasiveness, metastasis, or recurrence of the epithelial cell cancer. The kit comprises a detection reagent suitable for detecting the presence and distribution of giant obscurins or an amount of the gene product(s) encoding giant obscurins in cells of a tissue sample and instructions for using the detection reagent.